A total of 292,263 shares changed hands on the counter till 11:00AM (IST).

Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...

Here is a lowdown of the movers and shakers of Friday’s session on Dalal Street.

The generic would be used for treatment of asthma and chronic obstructive pulmonary disease.

Strides Pharma said it has ceased distribution of its ranitidine tablets in the US market.

The drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.

This is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...

The product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.

As per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries

Lupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...